Shruti Jolly
YOU?
Author Swipe
View article: Multi-institutional evaluation of direction-modulated brachytherapy tandems for cervical cancer
Multi-institutional evaluation of direction-modulated brachytherapy tandems for cervical cancer Open
Background: Direction-Modulated Brachytherapy (DMBT) offers a means of generating anisotropic radiation beams to create conformal dose distributions when in combination with image-guided adaptive brachytherapy (IGABT) workflow. The purpose…
View article: Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy
Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy Open
Circulating tumor cells (CTCs) are early signs of metastasis and can be used to monitor disease progression well before radiological detection by imaging. Using an ultrasensitive graphene oxide microfluidic chip nanotechnology built with g…
View article: Combining Novel Direction Modulated Brachytherapy Tandem-and-Ovoids Applicators for Treatment Planning of Multi-Institutional Cervical Cancer Cases: Removing Needles in Intracavitary-Interstitial Techniques
Combining Novel Direction Modulated Brachytherapy Tandem-and-Ovoids Applicators for Treatment Planning of Multi-Institutional Cervical Cancer Cases: Removing Needles in Intracavitary-Interstitial Techniques Open
View article: Direction Modulated Brachytherapy Tandem Model Applicators for Treatment Planning of Multi-Institutional Cervical Cancer Cases
Direction Modulated Brachytherapy Tandem Model Applicators for Treatment Planning of Multi-Institutional Cervical Cancer Cases Open
View article: Issue Information
Issue Information Open
View article: Use of machine learning to assess the prognostic utility of radiomic features for in-hospital COVID-19 mortality
Use of machine learning to assess the prognostic utility of radiomic features for in-hospital COVID-19 mortality Open
As portable chest X-rays are an efficient means of triaging emergent cases, their use has raised the question as to whether imaging carries additional prognostic utility for survival among patients with COVID-19. This study assessed the im…
View article: Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative
Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative Open
View article: Supplementary Tables from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas
Supplementary Tables from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas Open
Supplemental Tables 1-7
View article: Data from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas
Data from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas Open
Purpose:Carcinomas originate from epithelial tissues, which have apical (luminal) and basal orientations. The degree of luminal versus basal differentiation in cancer has been shown to be biologically important in some carcinomas and impac…
View article: Table S1 from IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients
Table S1 from IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients Open
Detail of Prospective Clinical Trials.
View article: Data from IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients
Data from IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients Open
Host immunity influences the impact of radiotherapy (RT) in cancer, but mechanistic connections remain obscure. In this study, we investigated the relationship of indoleamine 2,3-dioxygenase (IDO) systemic activity on clinical outcomes in …
View article: Table S1 from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer
Table S1 from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer Open
The Scores of CTCAE Pneumonitis and Radiation Pneumonitis
View article: Supplementary Data from A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease
Supplementary Data from A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease Open
Table S1 and Figure S1
View article: Supplementary Legend from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer
Supplementary Legend from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer Open
Supplementary Legend
View article: Supplementary Tables from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas
Supplementary Tables from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas Open
Supplemental Tables 1-7
View article: Data from IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients
Data from IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients Open
Host immunity influences the impact of radiotherapy (RT) in cancer, but mechanistic connections remain obscure. In this study, we investigated the relationship of indoleamine 2,3-dioxygenase (IDO) systemic activity on clinical outcomes in …
View article: Supplementary Figures from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas
Supplementary Figures from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas Open
Supplementary Figures 1-8 with legends
View article: Data from A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease
Data from A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease Open
Purpose:We recently reported that indoleamine 2, 3-dioxygenase (IDO) activity is significantly correlated with more distant metastasis and worse survival. The present study examined whether radiotherapy (RT) dose fractionation correlates w…
View article: Table S3 from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer
Table S3 from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer Open
prediction abilities in the previous reports
View article: A clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS)
A clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS) Open
View article: Supplementary Data from A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease
Supplementary Data from A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease Open
Table S1 and Figure S1
View article: Table S2 from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer
Table S2 from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer Open
patients' clinical and cytokines data
View article: Data from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer
Data from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer Open
Purpose:Radiation pneumonitis is an important adverse event in patients with non–small cell lung cancer (NSCLC) receiving thoracic radiotherapy. However, the risk of radiation pneumonitis grade ≥ 2 (RP2) has not been well predicted. This s…
View article: Table S2 from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer
Table S2 from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer Open
patients' clinical and cytokines data
View article: Supplementary Legend from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer
Supplementary Legend from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer Open
Supplementary Legend
View article: Data from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas
Data from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas Open
Purpose:Carcinomas originate from epithelial tissues, which have apical (luminal) and basal orientations. The degree of luminal versus basal differentiation in cancer has been shown to be biologically important in some carcinomas and impac…
View article: Data from A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease
Data from A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease Open
Purpose:We recently reported that indoleamine 2, 3-dioxygenase (IDO) activity is significantly correlated with more distant metastasis and worse survival. The present study examined whether radiotherapy (RT) dose fractionation correlates w…
View article: Table S1 from IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients
Table S1 from IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients Open
Detail of Prospective Clinical Trials.
View article: Data from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer
Data from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer Open
Purpose:Radiation pneumonitis is an important adverse event in patients with non–small cell lung cancer (NSCLC) receiving thoracic radiotherapy. However, the risk of radiation pneumonitis grade ≥ 2 (RP2) has not been well predicted. This s…
View article: Table S1 from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer
Table S1 from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer Open
The Scores of CTCAE Pneumonitis and Radiation Pneumonitis